117
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA

, , , , , , , , & show all
Pages 483-496 | Published online: 22 Feb 2017

References

  • ElsabahyMHeoGSLimSMSunGWooleyKLPolymeric nanostructures for imaging and therapyChem Rev201511519 10967 1101126463640
  • ElsabahyMWooleyKLCytokines as biomarkers of nanoparticle immunotoxicityChem Soc Rev20134212 5552 557623549679
  • ElsabahyMWooleyKLDesign of polymeric nanoparticles for biomedical delivery applicationsChem Soc Rev2012417 2545 256122334259
  • ChenYWuJJHuangLNanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapyMol Ther2010184 828 83420068551
  • XiongXBLavasanifarATraceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicinACS Nano201156 5202 521321627074
  • ReddyTLGarikapatiKRReddySGSimultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanomaSci Rep20166 3522327786239
  • SunTMDuJZYaoYDSimultaneous delivery of siRNA and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppressionACS Nano201152 1483 149421204585
  • ChenAMZhangMWeiDCo-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cellsSmall2009523 2673 267719780069
  • ElsabahyMShresthaRClarkCTaylorSLeonardJWooleyKLMultifunctional hierarchically assembled nanostructures as complex stage-wise dual-delivery systems for coincidental yet differential trafficking of siRNA and paclitaxelNano Lett2013135 2172 218123574430
  • KlooverJSden BakkerMAGelderblomHvan MeerbeeckJPFatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimensBr J Cancer2004902 304 30514974481
  • Al-RajabiRPatelSKetchumNSComparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunctionJ Gastrointest Oncol201563 259 26726029452
  • FitzmorrisPShoreibahMAnandBSSingalAKManagement of hepatocellular carcinomaJ Cancer Res Clin Oncol20151415 861 87625158999
  • KuoTCLuHPChaoCCThe tyrosine kinase inhibitor sorafenib sensitizes hepatocellular carcinoma cells to taxol by suppressing the HURP proteinBiochem Pharmacol2011822 184 19421549688
  • Dal LagoLD’HondtVAwadaASelected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumorsOncologist2008138 845 85818695262
  • LiuCChenZChenYImproving oral bioavailability of sorafenib by optimizing the “Spring” and “Parachute” based on molecular interaction mechanismsMol Pharm2016132 599 60826709621
  • WangXQFanJMLiuYOZhaoBJiaZRZhangQBioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to ratInt J Pharm20114191–2 339 34621843612
  • RaskopfEVogtASauerbruchTSchmitzVsiRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivoJ Hepatol2008496 977 98418845354
  • BogoradRLYinHZeigererANanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in miceNat Commun20145 386924844798
  • ElsabahyMNazaraliAFoldvariMNon-viral nucleic acid delivery: key challenges and future directionsCurr Drug Deliv201183 235 24421291381
  • MohamedNKHamadMAHafezMZWooleyKLElsabahyMNanomedicine in management of hepatocellular carcinoma: challenges and opportunitiesInt J Cancer Epub20161115
  • ZhangSZouJZhangFRapid and versatile construction of diverse and functional nanostructures derived from a polyphosphoester-based biomimetic block copolymer systemJ Am Chem Soc201213444 18467 1847423092249
  • ElsabahyMZhangSZhangFSurface charges and shell cross-links each play significant roles in mediating degradation, biofouling, cytotoxicity and immunotoxicity for polyphosphoester-based nanoparticlesSci Rep20133 331324264796
  • MaoCQDuJZSunTMA biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapyBiomaterials20113211 3124 313321277018
  • WangHXXiongMHWangYCZhuJWangJN-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liverJ Control Release20131662 106 11423266452
  • ZhangFZhangSPollackSFImproving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriersJ Am Chem Soc20151375 2056 206625629952
  • MorsiNGAliSMElsonbatySSPoly(glycerol methacrylate)-based degradable nanoparticles for delivery of small interfering RNAPharm Dev Technol In press2017
  • DePassLRAlternative approaches in median lethality (LD50) and acute toxicity testingToxicol lett1989492–3 159 1702690401
  • Van den HeuvelMJClarkDGFielderRJThe international validation of a fixed-dose procedure as an alternative to the classical LD50 testFood Chem Toxicol1990287 469 4822210519
  • MillerLCTainterMEstimation of the ED50 and its error by means of logarithmic-probit graph paperExp Biol Med1944572 261 264
  • HaroonMMDarGHJeyalakshmiDA designed recombinant fusion protein for targeted delivery of siRNA to the mouse brainJ Control Release2016228 120 13126948382
  • SatoYNoteYMaekiMElucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA deliveryJ Control Release2016229 48 5726995758
  • ZhangFSmolenJAZhangSDegradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infectionsNanoscale201576 2265 227025573163
  • LiuJYHuangWPangYZhuXZhouYYanDThe in vitro biocompatibility of self-assembled hyperbranched copolyphosphate nanocarriersBiomaterials20103121 5643 565120417961
  • ZouJZhangFZhangSPoly(ethylene oxide)-block- polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel deliveryAdv Healthc Mater201433 441 44823997013
  • LiALuehmannHPSunGSynthesis and in vivo pharmacokinetic evaluation of degradable shell cross-linked polymer nanoparticles with poly(carboxybetaine) versus poly(ethylene glycol) surface-grafted coatingsACS Nano2012610 8970 898223043240
  • ChenCKJonesCHMistriotisPPoly(ethylene glycol)-block-cationic polylactide nanocomplexes of differing charge density for gene deliveryBiomaterials20133437 9688 969924034497
  • QuadirMAMortonSWDengZJPEG-polypeptide block copolymers as pH-responsive endosome-solubilizing drug nanocarriersMol Pharm2014117 2420 243024813025
  • HeXFanJZhangFMulti-responsive hydrogels derived from the self-assembly of tethered allyl-functionalized racemic oligopeptidesJ Mater Chem B Mater Biol Med2014246 8123 813025485113
  • SunCYDouSDuJZYangXZLiYPWangJDoxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapyAdv Healthc Mater201432 261 27223852934
  • SunTMDuJZYanLFMaoHQWangJSelf-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA deliveryBiomaterials20082932 4348 435518715636
  • ElsabahyMDufresneMHLerouxJCPolymeric micelles as versatile carriers for drugs and nucleic acids deliveryTorchilinVAmijiMMaterials for NanomedicineHackensack, NYPan Stanford Publishing2010 169 234
  • ZhangSZouJElsabahyMPoly(ethylene oxide)-block-polyphosphester-based paclitaxel conjugates as a platform for ultrahigh paclitaxel-loaded multifunctional nanoparticlesChem Sci201345 2122 212625152808
  • ElsabahyMZhangMGanSMWaldronKCLerouxJCSynthesis and enzymatic stability of PEGylated oligonucleotide duplexes and their self-assemblies with polyamidoamine dendrimersSoft Matter200842 294 302
  • WenJMaoHQLiWLinKYLeongKWBiodegradable polyphosphoester micelles for gene deliveryJ Pharm Sci2004938 2142 215715236461
  • ElsabahyMWazenNPuxanNDelivery of nucleic acids through the controlled disassembly of multifunctional nanocomplexesAdv Funct Mater20091924 3862 3867
  • GroopmanJEItriLMChemotherapy-induced anemia in adults: incidence and treatmentJ Natl Cancer Inst19999119 1616 163410511589
  • LuJChuanXZhangHFree paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivoInt J Pharm20144711–2 525 53524858391
  • KimDHKimMDChoiCWAntitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymerNanoscale Res Lett201271 9122283905
  • MorisakiTUmebayashiMKiyotaACombining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitroAnticancer Res2013334 1387 139523564777
  • ChenWWuJShiHHepatic stellate cell coculture enables sorafenib resistance in Huh7 cells through HGF/c-Met/Akt and Jak2/Stat3 pathwaysBiomed Res Int20142014 76498125057499
  • ElsabahyMWooleyKLData mining as a guide for the construction of cross-linked nanoparticles with low immunotoxicity via control of polymer chemistry and supramolecular assemblyAcc Chem Res2015486 1620 163026011318
  • ElsabahyMSamarajeewaSRaymondJEClarkCWooleyKLShell-crosslinked knedel-like nanoparticles induce lower immunotoxicity than their non-crosslinked analogsJ Mater Chem B Mater Biol Med2013139 5241 5255
  • Harada-ShibaMYamauchiKHaradaATakamisawaIShimokadoKKataokaKPolyion complex micelles as vectors in gene therapy–pharmacokinetics and in vivo gene transferGene Ther200296 407 41411960317